Blansett Pharmacal Co is categorized under Drugs, Proprietaries, and Sundries in North Little Rock, AR and active since 2010.
Blansett Pharmacal Co was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Drugs, Proprietaries, and Sundries business, which does work in the B2C market, and is classified as a Drugs, Proprietaries, and Sundries, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Larry Blansett at the company’s single location by writing to 6142 Getty Drive, North Little Rock, Arkansas AR 72117 or by phoning (501) 758-8635. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Blansett Pharmacal Co |
Contact Person: | Larry Blansett |
Address: | 6142 Getty Drive, North Little Rock, Arkansas 72117 |
Phone Number: | (501) 758-8635 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Drugs, Proprietaries, and Sundries |
SIC Code: | 5122 |
NAICS Code: | 424210 |
Share This Business: |
Blansett Pharmacal Co was started in 2010 to provide professional Drugs, Proprietaries, and Sundries under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Larry Blansett for inquiries that concern Blansett Pharmacal Co by calling the company number (501) 758-8635, as your correspondence is most welcome. Additionally, the physical location of the single location of Blansett Pharmacal Co can be found at the coordinates 34.822282,-92.190987 as well as the street address 6142 Getty Drive in North Little Rock, Arkansas 72117.
For its online presence, you may visit Blansett Pharmacal Co’s website at and engage with its social media outlets through on Twitter and on Facebook.